Moderate, but not vigorous, intensity exercise training reduces C-reactive protein
Michael V Fedewa1,2, Elizabeth D Hathaway2,3, Simon Higgins2
1a Department of Kinesiology , The University of Alabama , Tuscaloosa , AL , USA.
Moderate-intensity cycling may be more effective than vigorous sprint interval cycling for reducing C-reactive protein in overweight young women. Both training types improved HDL-C and LDL-C levels.
Area of Science:
- Exercise Physiology
- Cardiometabolic Health
- Sports Science
Background:
- Sprint interval cycle training is popular but its effects on cardiometabolic disease risk factors, particularly in young women, require further investigation.
- Overweight and obese (OW/OB) young women are a key demographic for targeted health interventions.
- Understanding the comparative efficacy of different training intensities is crucial for public health recommendations.
Purpose of the Study:
- To compare the efficacy of moderate-intensity cycling (MOD-C) and vigorous sprint-interval cycling (VIG-SIC) over six weeks.
- To assess the impact of these training interventions on lipid profiles, insulin (INS), insulin resistance (HOMA-IR), and C-reactive protein (CRP).
- To evaluate these effects in inactive, OW/OB young women under conditions of matched energy expenditure.
Main Methods:
- Forty-four inactive, OW/OB young women (BMI ≥25 kg/m², waist circumference ≥88 cm) were randomized into MOD-C or VIG-SIC groups.
- Training involved supervised sessions three days/week for six weeks, with energy expenditure matched between groups.
- Measurements included dual x-ray absorptiometry for adiposity, lipid profiles, INS, HOMA-IR, and CRP.
Main Results:
- Both MOD-C and VIG-SIC improved high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C).
- Neither training program significantly altered total cholesterol, triglycerides, INS, or HOMA-IR.
- A statistically significant greater improvement in C-reactive protein (CRP) was observed in the MOD-C group compared to the VIG-SIC group (p=0.034).
Conclusions:
- Moderate-intensity cycling may offer superior benefits for reducing inflammation, as indicated by CRP levels, compared to vigorous sprint interval cycling.
- While both training modalities positively impact certain aspects of lipid profiles, neither effectively reduced insulin resistance markers in this cohort.
- Further research is warranted to explore optimal exercise prescriptions for improving cardiometabolic health in young, OW/OB women.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Atherosclerosis III: Management
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease III: Medical Management
